What is NAION, the rare eye condition linked to GLP-1 drugs?
Watch to understand the emerging safety concerns, clinical evidence and changing debate around access to obesity medicines.
Published Nov 16, 2026 | 1:30 PM ⚊ Updated Nov 16, 2026 | 1:30 PM